Assessment of preoperative noninvasive ventilation before lung cancer surgery: The preOVNI randomized controlled study
The Journal of Thoracic and Cardiovascular Surgery Dec 05, 2019
Paleiron N, Grassin F, Lancelin C, et al. - Researchers conducted the preOVNI study, a randomized controlled open-label study, to ascertain if preoperative noninvasive ventilation (NIV) could decrease postoperative complications after lung cancer surgery. They randomly assigned 300 adult patients with planned lung cancer resection and with at least one cardiac or respiratory comorbidity to preoperative NIV (at least 7 days and 4 h/day) or no NIV. The median NIV duration of 8 days was reported in the NIV group. Outcomes yielded no evidence indicating the benefit of preoperative NIV before lung cancer surgery. Postoperative complication rates were: 42.6% in NIV group and 44.8% in no-NIV group. No-NIV group had higher rate of pneumonia relative to NIV group, but statistical significance was not achieved (28.0 vs 37.7%, respectively). Multivariable analysis indicated no impact of the type of surgery (open or mini-invasive) on these results.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries